These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 24028852

  • 1. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U, Ebru A, Murat E, Levent Y.
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [Abstract] [Full Text] [Related]

  • 2. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N, Soysal S, Sayan S, Yildizhan B, Karaman E, Cetin O, Tolunay HE, Yildizhan R.
    Gynecol Obstet Invest; 2018 Nov; 83(6):569-575. PubMed ID: 29223999
    [Abstract] [Full Text] [Related]

  • 3. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A, Hussain M, Rishworth JR, Rees MC.
    Cochrane Database Syst Rev; 2015 Apr 30; (4):CD002126. PubMed ID: 25924648
    [Abstract] [Full Text] [Related]

  • 4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE, Cooke I, Rees M.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD002126. PubMed ID: 16235297
    [Abstract] [Full Text] [Related]

  • 5. Vascular effect of levonorgestrel intrauterine system on heavy menstrual bleeding: is it associated with hemodynamic changes in uterine, radial, and spiral arteries?
    Şahin H, Güngören A, Sezgin B, Ün B, Şahin EA, Dolapçioğlu K, Bayik RN.
    J Obstet Gynaecol; 2021 Jan 19; 41(1):89-93. PubMed ID: 32573299
    [Abstract] [Full Text] [Related]

  • 6. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov 19; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

  • 7. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF.
    Hum Reprod; 1998 May 19; 13(5):1210-7. PubMed ID: 9647549
    [Abstract] [Full Text] [Related]

  • 8. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Contracept Reprod Health Care; 2001 Jun 19; 6(2):93-101. PubMed ID: 11518454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
    Kriplani A, Singh BM, Lal S, Agarwal N.
    Int J Gynaecol Obstet; 2007 Jun 19; 97(3):190-4. PubMed ID: 17382331
    [Abstract] [Full Text] [Related]

  • 11. Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma.
    Socolov D, Blidaru I, Tamba B, Miron N, Boiculese L, Socolov R.
    Eur J Contracept Reprod Health Care; 2011 Dec 19; 16(6):480-7. PubMed ID: 21942657
    [Abstract] [Full Text] [Related]

  • 12. The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding.
    Shaw V, Vandal AC, Coomarasamy C, Ekeroma AJ.
    Aust N Z J Obstet Gynaecol; 2016 Dec 19; 56(6):619-623. PubMed ID: 27696346
    [Abstract] [Full Text] [Related]

  • 13. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J, Heikinheimo O, Lähteenmäki P, Suhonen S.
    Hum Reprod; 2015 Jul 19; 30(7):1580-8. PubMed ID: 25990577
    [Abstract] [Full Text] [Related]

  • 14. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun 19; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 15. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET, Yigit R, Molenberghs G, Straetmans D, Ombelet W.
    Contraception; 2007 Aug 19; 76(2):91-5. PubMed ID: 17656176
    [Abstract] [Full Text] [Related]

  • 16. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
    Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E.
    Acta Oncol; 2016 Nov 19; 55(11):1281-1284. PubMed ID: 27148621
    [Abstract] [Full Text] [Related]

  • 17. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
    Fong YF, Singh K.
    Contraception; 1999 Jul 19; 60(1):51-3. PubMed ID: 10549453
    [Abstract] [Full Text] [Related]

  • 18. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C, Laberge PY, Boutin A, Thériault MA, Valcourt F, Lemyre M, Maheux-Lacroix S.
    Hum Reprod Update; 2020 Feb 28; 26(2):302-311. PubMed ID: 31990359
    [Abstract] [Full Text] [Related]

  • 19. Levonorgestrel-releasing intrauterine system versus conventional medical therapy for heavy menstrual bleeding in the Asia-Pacific region.
    Lee BS, Ling X, Asif S, Kraemer P, Hanisch JU, Inki P.
    Int J Gynaecol Obstet; 2013 Apr 28; 121(1):24-30. PubMed ID: 23340271
    [Abstract] [Full Text] [Related]

  • 20. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D, Janssens D, Andrade A.
    Eur J Contracept Reprod Health Care; 2009 Apr 28; 14(2):103-10. PubMed ID: 19340705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.